The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Kunming Longjin Price, Forecast, Insider, Ratings, Fundamentals & Signals
-4.94% CNY5.58
America/New_York / 6 mai 2024 @ 00:24
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2 234.79 mill |
| EPS: | -0.200 |
| P/E: | -27.90 |
| Earnings Date: | May 21, 2024 |
| SharesOutstanding: | 400.50 mill |
| Avg Daily Volume: | 19.57 mill |
| RATING 2024-05-06 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Sell | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -27.90 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.61x |
| Company: PE -27.90 | industry: PE 45.57 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY-0.377 (-106.76%) CNY-5.96 |
| Date: 2024-05-03 |
| Expected Trading Range (DAY) |
|---|
|
CNY 5.06 - 6.10 ( +/- 9.32%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY5.58 (-4.94% ) |
| Volume | 0.105 mill |
| Avg. Vol. | 19.57 mill |
| % of Avg. Vol | 0.539 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 002750.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
002750.SZ
Kunmig Longjin Pharmaceutical Co., Ltd. develops, produces, and sells natural botanicals and chemical freeze-dried powder injections in China. The company offers Chinese, biochemical, chemical, cardio-cerebral vascular, and digestive system medicines; immune system and first aid medications; and vitamins, minerals, and enteral and parenteral nutrition products. It also engages in the industrial hemp plantation business. The company was founded in 1996 and is headquartered in Kunming, China.